SynthesisBMJ open2026
Left atrial strain assessment in mitral regurgitation: a systematic review.
Synthesis in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesMitral regurgitation (MR) induces progressive atrial remodelling and dysfunction, yet conventional metrics may underestimate early mechanical impairment. This systematic review synthesised evidence on left atrial strain (LAS) across MR phenotypes, its prognostic utility and its response to intervention.
designSystematic review conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. DATA SOURCES: MEDLINE, PubMed, Embase, CENTRAL and Web of Science were searched from 1 January 2010 to 10 July 2026. ELIGIBILITY CRITERIA: Studies of adult patients with MR of any aetiology or severity using speckle-tracking echocardiography to report quantitative LAS. Case reports, reviews, conference abstracts without full text and non-English publications were excluded. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted data and assessed the risk of bias using the Risk of Bias in Non-Randomised Studies of Exposures tool, with a third reviewer resolving disagreements. Substantial heterogeneity precluded quantitative meta-analysis.
resultsLeft atrial reservoir strain (LASr) was universally reduced in patients with MR compared with controls across all aetiologies. Secondary MR demonstrated more severe impairment than primary MR, reflecting combined volume and pressure overload. Progressive LAS deterioration accompanied increasing MR severity, with LASr independently predicting surgical necessity and outperforming left ventricular global longitudinal strain as a severity marker. Multiple prognostic thresholds demonstrated independent predictive value for adverse outcomes: LASr <35% predicted cardiovascular events, while LASr ≤15% in secondary MR independently predicted mortality. Postintervention LAS responses demonstrated substantial heterogeneity; patients achieving ≥15% LASr improvement experienced significantly lower all-cause mortality and heart failure hospitalisation, establishing LAS recovery as a surrogate marker of successful reverse remodelling.
conclusionsLASr is a sensitive, consistent marker of atrial dysfunction in MR, identifying mechanical impairment prior to irreversible remodelling. As most supporting evidence is retrospective and single-centre, further prospective validation will help establish standardised thresholds for clinical use. PROSPERO REGISTRATION NUMBER: CRD420251126721.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.